Clinical Translation of Activated Optical Fluorescence Methods and Technologies for Sensitive Cancer Detection in Vivo (R01)

The purpose of this grant is to bring a highly sensitive imaging technology capable of detecting very small (1-3 mm³) tumors in vivo to clinical utility. Please note this grant supports translation of already developed technologies for small tumor detection in vivo. It is not intended to support continued development of novel agents or preclinical studies.

Funding: $500,000 per year 

Duration: 5 years

Research Authority due dates: 10 days prior to submission 

LOI (encouraged) due date: 10.1.21, 13.9.21

Full proposal due dates: 10.2.21, 13.10.21